[go: up one dir, main page]

FI953866A7 - Indolin-2-johdannaisia - Google Patents

Indolin-2-johdannaisia

Info

Publication number
FI953866A7
FI953866A7 FI953866A FI953866A FI953866A7 FI 953866 A7 FI953866 A7 FI 953866A7 FI 953866 A FI953866 A FI 953866A FI 953866 A FI953866 A FI 953866A FI 953866 A7 FI953866 A7 FI 953866A7
Authority
FI
Finland
Prior art keywords
indoline
derivatives
Prior art date
Application number
FI953866A
Other languages
English (en)
Swedish (sv)
Other versions
FI953866A0 (fi
FI112652B (fi
Inventor
Toru Esaki
Takashi Emura
Eiichi Hoshino
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of FI953866A0 publication Critical patent/FI953866A0/fi
Publication of FI953866A7 publication Critical patent/FI953866A7/fi
Application granted granted Critical
Publication of FI112652B publication Critical patent/FI112652B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
FI953866A 1993-02-17 1995-08-16 Menetelmä uusien terapeuttisesti käyttökelpoisten indolin-2-onijohdannaisten valmistamiseksi FI112652B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP6729793 1993-02-17
JP6729793 1993-02-17
JP16726293 1993-05-31
JP16726293 1993-05-31
JP9400235 1994-02-17
PCT/JP1994/000235 WO1994019322A1 (en) 1993-02-17 1994-02-17 Indolin-2-one derivative

Publications (3)

Publication Number Publication Date
FI953866A0 FI953866A0 (fi) 1995-08-16
FI953866A7 true FI953866A7 (fi) 1995-08-16
FI112652B FI112652B (fi) 2003-12-31

Family

ID=26408486

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953866A FI112652B (fi) 1993-02-17 1995-08-16 Menetelmä uusien terapeuttisesti käyttökelpoisten indolin-2-onijohdannaisten valmistamiseksi

Country Status (19)

Country Link
US (5) US5952511A (fi)
EP (1) EP0685463B1 (fi)
JP (1) JP3419539B2 (fi)
KR (1) KR100226310B1 (fi)
CN (1) CN1046268C (fi)
AT (1) ATE217864T1 (fi)
AU (1) AU6044894A (fi)
CA (1) CA2156287C (fi)
CZ (1) CZ290504B6 (fi)
DE (1) DE69430664T2 (fi)
ES (1) ES2176236T3 (fi)
FI (1) FI112652B (fi)
HU (1) HUT74105A (fi)
MY (1) MY128102A (fi)
NO (1) NO305201B1 (fi)
PL (1) PL176710B1 (fi)
RU (1) RU2128170C1 (fi)
TW (1) TW281669B (fi)
WO (1) WO1994019322A1 (fi)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878728B1 (en) 1999-06-11 2005-04-12 Vertex Pharmaceutical Incorporated Inhibitors of aspartyl protease
US20040122000A1 (en) 1981-01-07 2004-06-24 Vertex Pharmaceuticals Incorporated. Inhibitors of aspartyl protease
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US5783701A (en) 1992-09-08 1998-07-21 Vertex Pharmaceuticals, Incorporated Sulfonamide inhibitors of aspartyl protease
DE69429584T2 (de) * 1993-11-26 2002-08-08 Tanabe Seiyaku Co., Ltd. 2-oxoindolin-derivate als cholecystokinin rezeptor antagonisten
CA2183653A1 (en) * 1994-03-07 1995-09-14 Roger Dennis Tung Sulphonamide derivatives as aspartyl protease inhibitors
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
US6004957A (en) * 1995-06-07 1999-12-21 Vertex Pharmaceuticals, Incorporated Sulfonamide inhibitors of aspartyl protease
WO1997033867A1 (en) * 1996-03-11 1997-09-18 Ube Industries, Ltd. Process for the preparation of optically active indole compounds
WO1998002419A1 (en) * 1996-07-12 1998-01-22 Chugai Seiyaku Kabushiki Kaisha Cancer cell proliferation inhibitors
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
CA2335477C (en) 1998-06-19 2010-11-30 Vertex Pharmaceuticals Incorporated Sulfonamide inhibitors of aspartyl protease
AU1648600A (en) * 1998-12-04 2000-06-26 Neurosearch A/S Use of isatin derivatives as ion channel activating agents
US6605623B1 (en) 1998-12-18 2003-08-12 Bristol-Myers Squibb Pharma Co. N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AU2318600A (en) * 1999-01-29 2000-08-18 Chugai Seiyaku Kabushiki Kaisha Chondrongenesis promotors and indolin-2-one derivatives
ATE425142T1 (de) * 1999-04-23 2009-03-15 Vertex Pharma Inhibitoren von c-jun n-terminal kinasen (jnk)
US6391907B1 (en) * 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
AU783504C (en) * 1999-11-23 2006-08-03 Methylgene Inc. Inhibitors of histone deacetylase
WO2001066142A1 (en) * 2000-03-10 2001-09-13 Chugai Seiyaku Kabushiki Kaisha Preparations for chondrogenesis
US7612065B2 (en) 2000-04-21 2009-11-03 Vertex Pharmaceuticals Incorporated Inhibitors of c-JUN N-terminal kinases (JNK)
EP1363881A2 (en) * 2000-06-21 2003-11-26 Bristol-Myers Squibb Pharma Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
JP2004516237A (ja) 2000-06-21 2004-06-03 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー ケモカイン受容体活性調節剤としてのピペリジンアミド類
US7645886B2 (en) * 2002-12-20 2010-01-12 Ciba Specialty Corporation Synthesis of amines and intermediates for the synthesis thereof
CN1251698C (zh) * 2003-01-30 2006-04-19 普文英 一种治疗内毒素血症的板蓝根提取物和用途
CA2583660C (en) * 2004-10-27 2013-02-12 Toshiaki Yamaguchi Indoline compound and process for producing the same
US20080030974A1 (en) * 2006-08-02 2008-02-07 Abu-Ageel Nayef M LED-Based Illumination System
US20090050905A1 (en) * 2007-08-20 2009-02-26 Abu-Ageel Nayef M Highly Efficient Light-Emitting Diode
WO2010090862A2 (en) * 2009-01-21 2010-08-12 Abu-Ageel Nayef M Illumination system utilizing wavelength conversion materials and light recycling
EP2493297B1 (en) * 2009-10-30 2016-08-17 Merck Sharp & Dohme Corp. Heterocycle amide t-type calcium channel antagonists
CN102516153B (zh) * 2011-12-14 2014-03-12 南京工业大学 5-氟吲哚-2-酮-3-脲类化合物及其制备方法和应用
PL3071206T3 (pl) 2013-11-22 2022-01-17 CL BioSciences LLC Antagoniści gastryny (eg yf476, netazepid) do leczenia i zapobiegania osteoporozie
KR102161674B1 (ko) * 2014-02-18 2020-10-05 주식회사 대웅제약 이사틴 유도체 및 이의 제조방법
CN113456631B (zh) * 2021-08-06 2022-06-21 徐州医科大学 一种靶向acsl1的小分子药物及其在治疗子宫内膜癌中的应用
CN117777002A (zh) * 2023-12-04 2024-03-29 华南理工大学 一种3,3-二取代氧化吲哚衍生物的不对称合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820834A (en) * 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
JPS62234080A (ja) 1985-12-20 1987-10-14 Kissei Pharmaceut Co Ltd インドリン−2−オン誘導体
JPS62228072A (ja) 1985-12-20 1987-10-06 Kissei Pharmaceut Co Ltd 3−アミノインドリン−2−オン誘導体
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
JPS62270576A (ja) 1986-05-19 1987-11-24 Kissei Pharmaceut Co Ltd イサチン誘導体
JPS62156771A (ja) * 1986-12-19 1987-07-11 Tokyo Shokai:Kk 処方箋処理装置
JPS63156771A (ja) 1986-12-19 1988-06-29 Kissei Pharmaceut Co Ltd 3−アミノインドリン−2−オン誘導体
US4876259A (en) * 1987-01-05 1989-10-24 E. I. Du Pont De Nemours And Company 3,3-disubstituted indolines
EP0336356A3 (en) * 1988-04-05 1991-09-25 Abbott Laboratories Derivatives of tryptophan as cck antagonists
ATE208400T1 (de) * 1990-08-31 2001-11-15 Warner Lambert Co Pro-medikamente für cck-antagonisten
WO1992007830A2 (en) * 1990-10-29 1992-05-14 Pfizer Inc. Oxindole peptide antagonists
CA2055094A1 (en) * 1990-11-13 1992-05-14 Mark G. Bock Cholecystokinin antagonist
JPH05104510A (ja) * 1991-10-18 1993-04-27 Inax Corp 基板へのモルタル塗布方法

Also Published As

Publication number Publication date
JPH0748349A (ja) 1995-02-21
PL310168A1 (en) 1995-11-27
EP0685463A1 (en) 1995-12-06
CA2156287C (en) 2005-12-27
FI953866A0 (fi) 1995-08-16
FI112652B (fi) 2003-12-31
US6127544A (en) 2000-10-03
NO953235L (no) 1995-10-09
US5952511A (en) 1999-09-14
MY128102A (en) 2007-01-31
ATE217864T1 (de) 2002-06-15
US6114536A (en) 2000-09-05
HU9502415D0 (en) 1996-05-28
DE69430664D1 (de) 2002-06-27
NO305201B1 (no) 1999-04-19
KR960701011A (ko) 1996-02-24
US6031111A (en) 2000-02-29
CA2156287A1 (en) 1994-09-01
ES2176236T3 (es) 2002-12-01
CZ209695A3 (en) 1995-12-13
HUT74105A (en) 1996-11-28
AU6044894A (en) 1994-09-14
EP0685463B1 (en) 2002-05-22
TW281669B (fi) 1996-07-21
EP0685463A4 (fi) 1996-01-03
CN1117727A (zh) 1996-02-28
KR100226310B1 (ko) 1999-10-15
NO953235D0 (no) 1995-08-17
DE69430664T2 (de) 2003-01-30
CN1046268C (zh) 1999-11-10
JP3419539B2 (ja) 2003-06-23
PL176710B1 (pl) 1999-07-30
CZ290504B6 (cs) 2002-08-14
WO1994019322A1 (en) 1994-09-01
RU2128170C1 (ru) 1999-03-27
US6207836B1 (en) 2001-03-27

Similar Documents

Publication Publication Date Title
DE69407573D1 (de) Fluorsiloxanhydrogele
DE69430498D1 (de) Personenrufübertragungssystem
DE69411848D1 (de) Furanylinsektizide
DE69433968D1 (de) Kommunikationsnetwerkverwaltung
DE69434288D1 (de) Drehtellerheizvorrichtung
DE69430989D1 (de) Stromleitungskommunikationsanalysator
DE69432420T2 (de) Bohrgestängeanordnung
DE69429469D1 (de) Halbleiterbildaufnehmer
BR9405832A (pt) Imidazoazinas
DE69429756D1 (de) Difibrillationsgerät
FI953866A7 (fi) Indolin-2-johdannaisia
DE69432802D1 (de) Rührertank
DE69432804D1 (de) Walzenausrichtvorrichtung
DE69413933D1 (de) Antitussiva
ATA146094A (de) Windsichter
DE59407673D1 (de) 2-Oximino-2-phenyl-acetamide
DE69432138D1 (de) Spreizspektrumsignalempfänger
DE69410500D1 (de) Mehrplattenspieler
DE59410180D1 (de) 4-Cyanophenyliminoheterocyclen
DE59309062D1 (de) Mischer-Trockner
ATA179094A (de) Kettenschloss
ATA212793A (de) Sportschuh
ATA194593A (de) Sportschuh
DE69433472D1 (de) Recognin vakzine
ATE144907T1 (de) Rollbrett